Prevalence of Viral Hepatitis B, C, and D in Kazakhstan.

BACKGROUND

Viral hepatitis is a major burden for the healthcare system worldwide. Up to date, a comprehensive analysis of the prevalence of viral hepatitis in Kazakhstan and Central Asia has not been carried out yet. Our epidemiological study aimed at investigating the frequency and spread of viral hepatitis B, C, and D depending on age and sex in Kazakhstan (5-year period).

MATERIALS AND METHODS

We utilized the data from the primary registration of the incidence of hepatitis B, C, and D in 18 regions of Kazakhstan (period: from 2015 to 2020). Age indicators, gender, and territorial characteristics of registered cases were determined and analysed. The data were obtained from the state information system "Electronic Register of Dispensary Patients", based on the International Classification of Diseases-10 for coding diseases.

RESULTS

During the period studied, 268 975 cases of hepatitis B, C, and D were detected in Kazakhstan. Hepatitis B was registered in  = 109 734 cases. In women, the incidence rate was 40.6% of all cases ( = 44545), and in men it was 59.4% ( = 65189) of all cases ( ≤ 0.01). Hepatitis D was detected in 8 656 cases, of which 58.3% ( = 5049) were in men and 41.7% ( = 3607) in women ( ≤ 0.01). Hepatitis C was registered in  = 159 585 cases. The rate was higher in the male population (54.6%;  = 82 203) compared to women 45.4% ( = 68382) ( ≤ 0.01). In 2020 (in comparison with 2015), there was a significant increase in the incidence of hepatitis D by 68.3%, hepatitis B by 49.8%, and hepatitis C by 46.4%. The largest prevalence of hepatitis D was recorded in 2016 which is 22.3% higher compared to 2020. A significant increase in hepatitis C was recorded in 2019 compared to 2015, where indicators were 49.2% higher.

CONCLUSION

An analysis of the prevalence of hepatitis B, C, and D showed an increase in new cases in Kazakhstan. These findings indicate the need to develop effective preventive measures and screening strategies among people in a high-risk group. The results of the study can be used for the development of a national program to combat the spread of viral hepatitis.